lexingtonbiologo.jpg
Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement
November 29, 2018 23:46 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed...
lexingtonbiologo.jpg
Lexington Announces Non-Brokered Private Placement
August 27, 2018 09:00 ET | Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...
lexingtonbiologo.jpg
Lexington Announces First Multicenter Clinical Study Site
August 21, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
lexingtonbiologo.jpg
Lexington Biosciences Announces Results of Annual General Meeting
July 02, 2018 19:32 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes...
lexingtonbiologo.jpg
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
June 11, 2018 07:45 ET | Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, June 11,...
lexingtonbiologo.jpg
Lexington Announces Brokered Private Placement
May 04, 2018 07:00 ET | Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, B.C., May 04, 2018 (GLOBE...
lexingtonbiologo.jpg
Lexington Receives Approval to Commence Clinical Study
January 24, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
lexingtonbiologo.jpg
Lexington Completes IRB Submission in Preparation for Clinical Study
January 18, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
lexingtonbiologo.jpg
Lexington Biosciences Announces Exercise of Warrants
January 11, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...